Data Foundry

Drug recalls 2016

CITRULLINE — Class I drug recall D-0674-2016

Terminated recall by Medisca Inc, reported 2016-02-24, distributed nationwide. Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and result

Recall numberD-0674-2016
Product typeDrug
ClassificationClass I
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmMedisca Inc, Plattsburgh, NY, United States
Recall initiated2014-02-14
Classified2016-02-17
Reported by FDA2016-02-24
Terminated2016-02-17
DistributedNationwide (US)
Countries outside the USAU
Reason classeslabeling
NDC38779-1186-04, 38779-1186-05, 38779-1186-08, 38779-1186-09
Lot numbers95482/A, 95482/B, 95482/C, 95482/D, 96453/A, 96453/B, 96453/C, 96453/D
Expiration dates2014-10-31

Product

CITRULLINE (L) in 25 g, 100 g, 500 g and 1 kg plastic bottles, White crystals or crystalline powder, odorless, For Use and distribution in prescription compounding, manufacturing, processing, or repackaging only in accordance with FDA regulations and applicable law, Packaged by Medisca Inc. Plattsburgh, NY 12901, USA, NDC #s: 38779-1186-4 (25 g), 38779-1186-5 (100 g), 38779-1186-8 (500 g), 38779-1186-9 (1 kg).

Reason for recall

Labeling: Label Mix-Up: FDA tested samples of API from Medisca, labeled as to contain L-Citrulline, and results revealed no L-Citrulline was present. Levels of N-acetyl-leucine were found instead.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0674-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.